Clinical Significance and Therapeutic Potential of Long Non-Coding RNA H19 in Soft Tissue Sarcoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Long non-coding RNA (lncRNA) H19 is a key factor in various human cancers.
• The specific role of H19 in soft tissue sarcoma (STS) remains undefined.
• Investigating H19's function in STS is crucial for understanding cancer development.

Purpose of the Study:

• To define the role of H19 in the pathogenesis of soft tissue sarcoma (STS).
• To evaluate the prognostic value of H19 expression in STS patients.
• To explore the functional impact of H19 in STS cell lines.

Main Methods:

• Analysis of H19 expression in STS cell lines and human STS tissue microarrays (n=150).
• RNA in situ hybridization to assess H19 expression patterns.
• Univariate and multivariate analyses for prognostic evaluation and Gapmer-based H19 knockdown in STS cell lines.

Main Results:

• Low H19 expression was linked to poorer prognosis in univariate analysis (p=0.044).
• Advanced age and large tumor size were independent predictors of worse survival.
• H19 knockdown reduced STS cell growth and enhanced apoptosis.

Conclusions:

• H19 likely contributes to the pathogenesis of soft tissue sarcoma.
• Further research is needed to confirm H19's prognostic significance in STS.
• H19-targeting strategies show potential for STS therapeutic development.